Age | |
---|---|
Median (range) | 57 (30 to 76) |
n (%) | |
Menopausal status | |
Premenopausal | 4 (12) |
Postmenopausal | 30 (88) |
Primary breast cancer at presentation | 23 (68) |
Tumor size (cm) | |
1-1.9/2-4.9/≥5/UN | 3 (13)/14 (61)/2 (9)/4 (17) |
Lymph nodes | |
0/1-3/≥4/UN | 7 (30)/6 (26)/8 (35)/2 (9) |
Grade | |
II/III/UN | 8 (35)/11 (48)/4 (17) |
Disease sites* | |
1 | 5 (15) |
2 | 15 (44) |
3 | 5 (15) |
≥4 | 8 (23) |
Unknown | 1 (3) |
Predominantly visceral disease | |
Yes | 11 (32) |
No | 22 (64) |
Unknown | 1 (3) |
Line of treatment ** | |
0 | 18 (53) |
1 | 7 (21) |
≥2 | 9 (26) |
ER/PR status | |
Positive | 16 (47) |
Negative | 13 (38) |
Unknown | 5 (15) |
HER2 status | |
Positive*** | 7 (20) |
Negative | 23 (68) |
Unknown | 4 (12) |